Clinical Safety

A comprehensive meta-analysis of 24 randomized controlled trials indicates that mesenchymal stem cell therapy can reduce the risk of death by 36% in patients suffering from viral lung injury. This revelation comes at a critical time when traditional supportive care often struggles to keep pace with

Patients using the new telehealth portal can have their presbyopia prescriptions processed and shipped directly to their residences following a successful virtual assessment. For many adults over the age of 45, the sudden inability to focus on a restaurant menu or a smartphone screen represents a

Monitoring biological age through specific protein biomarkers offers a new pathway for creating personalized survivorship care plans that go beyond cancer remission. This revelation comes from a significant study conducted by researchers at Georgetown University’s Lombardi Comprehensive Cancer

Recent Phase Ib clinical data revealed that patients with recurring major depressive disorder experienced a fifty percent reduction in depression scores just eight days after beginning treatment with Zalsupindole. This remarkable finding underscores a significant pivot within the medical community

ALLO-329 Shows Rapid Benefits for Systemic Sclerosis, an experimental therapy that utilizes healthy donor cells to create an available, pre-manufactured product designed to address the high cost and logistical hurdles of cell therapy. Systemic sclerosis, a devastating autoimmune condition often

Researchers have identified that inhibiting the Wee1 protein inadvertently disables a critical switch required for all fast-proliferating cells to begin the DNA replication process. For decades, the pharmaceutical industry has focused on Wee1 as a potential vulnerability for tumors that lack the